- Home
- Automated
- List of product information
- HAEMODIALYSIS CONCENTRATE NKFS-02 (ACID) FOR BICARBONATE DIALYSIS [SIN07943P]
HAEMODIALYSIS CONCENTRATE NKFS-02 (ACID) FOR BICARBONATE DIALYSIS [SIN07943P]
Active ingredients: HAEMODIALYSIS CONCENTRATE NKFS-02 (ACID) FOR BICARBONATE DIALYSIS
Last updated 26 October 2025
Product Info
HAEMODIALYSIS CONCENTRATE NKFS-02 (ACID) FOR BICARBONATE DIALYSIS
[SIN07943P]
Product information
Active Ingredient and Strength | CALCIUM CHLORIDE - 6.47 G/L |
Dosage Form | SOLUTION |
Manufacturer and Country | B BRAUN MEDICAL INDUSTRIES SDN BHD - MALAYSIA |
Registration Number | SIN07943P |
Licence Holder | B. BRAUN SINGAPORE PTE LTD |
Forensic Classification | GENERAL SALE LIST |
Anatomical Therapeutic Chemical (ATC) code | B05ZA |
Indications
The indications below apply exclusively to the ready-to-use bicarbonate haemodialysis solution prepared from acid concentrate and bicarbonate concentrate following the specified dilution procedure:
Acute renal failure
Chronic renal failure
Hyperhydration
Intoxications
Compensation of acid-base and electrolyte balances
Adjustment of the blood / plasma / body temperature
Dosage
Unless otherwise directed, mix 1.000 | NKFS-0x (acid concentrate) and 1.225 | Sodium Bicarbonate 8.4% with 32.775 l water of suitable quality. Please refer to the product label of the acid concentrate used for details of the mixing ratio.
Mode and duration of administration
For extracorporeal bicarbonate haemodialysis or bicarbonate haemodiafiltration.
The duration of administration must be determined on an individual basis.
Contraindications
Hyperkalaemia with the use of a potassium-containing acidic bicarbonate haemodialysis concentrate
Hypokalaemia with the use of a potassium-free acidic bicarbonate haemodialysis concentrate
Intractable coagulopathy
In patients with unstable circulation and/or unstable blood pressure, a different extracorporeal method of treatment may be indicated.